FluMist Quadrivalent: alternative to Fluenz Tetra

FluMist Quadrivalent is an intranasal influenza vaccine that can be used to vaccinate children once supplies of Fluenz Tetra are exhausted.

Despite the wording on the packaging, in the UK FluMist Quadrivalent should only be used in children between 24 months  and 18 years of age.
Despite the wording on the packaging, in the UK FluMist Quadrivalent should only be used in children between 24 months and 18 years of age.

As a result of a supply shortage there are insufficient supplies of Fluenz Tetra to meet the timelines for the 2015/16 influenza vaccination programme. In order to cover the deficit, AstraZeneca has reached an agreement with the MHRA to supply two batches of pharmaceutically identical US labelled FluMist Quadrivalent in addition to the usual Fluenz Tetra stock. Supplies of FluMist Quadrivalent will be distributed once existing stocks of Fluenz Tetra have been delivered.

Further information
View Fluenz Tetra drug record
Summary of Product Characteristics
Manufacturer: AstraZeneca

As the two products are identical all FluMist Quadrivalent packs will be supplied with a UK PIL which should be made available with each dose. The US leaflet in the packs should be discarded. FluMist Quadrivalent should be used in accordance with the UK SPC for Fluenz Tetra.

The FluMist Quadrivalent batches being supplied (FL2113 & FL2118) must not be used after February 24th 2016. A pre-planned withdrawal of any unused stock will begin on January 25th 2016.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases